Radiotherapy and Renal Cell Carcinoma: A Continuing Saga

被引：10

作者：

Spyropoulou, Despoina ^{[1
]}

Tsiganos, Panagiotis ^{[2
]}

Dimitrakopoulos, Foteinos-Ioannis ^{[3
,4
]}

Tolia, Maria ^{[5
]}

Koutras, Angelos ^{[3
]}

Velissaris, Dimitris ^{[6
,7
]}

Lagadinou, Maria ^{[6
]}

Papathanasiou, Nikolaos ^{[8
]}

Gkantaifi, Areti ^{[9
]}

Kalofonos, Haralabos ^{[3
]}

Kardamakis, Dimitrios ^{[1
]}

机构：

[1] Univ Patras, Med Sch, Dept Radiat Oncol, Univ Campus, Patras 26504, Greece

[2] Univ Patras, Dept Med, Clin Radiol Lab, Patras, Greece

[3] Univ Hosp Patras, Dept Med, Div Oncol, Patras, Greece

[4] Univ Patras, Med Sch, Clin & Mol Oncol Lab, Patras, Greece

[5] Univ Crete, Med Sch, Univ Hosp Heraklion, Radiotherapy Dept, Iraklion, Greece

[6] Univ Hosp Patras, Emergency Dept, Patras, Greece

[7] Univ Hosp Patras, Internal Med Dept, Patras, Greece

[8] Univ Hosp Patras, Nucl Med & PET CT Dept, Patras, Greece

[9] Interbalkan Med Ctr, Radiotherapy Dept, Thessaloniki, Greece

来源：

IN VIVO | 2021年 / 35卷 / 03期

关键词：

Renal cell cancer; radiotherapy; radioresistance; radiosensitivity; oligometastatic disease; stereotactic body radiation therapy; review; EXTERNAL-BEAM RADIOTHERAPY; STEREOTACTIC BODY RADIOTHERAPY; LONG-TERM OUTCOMES; BRAIN METASTASES; POSTOPERATIVE RADIOTHERAPY; RADIATION-THERAPY; RANDOMIZED-TRIAL; PROGNOSTIC-FACTORS; SYSTEMIC THERAPY; STAGE-II;

D O I：

10.21873/invivo.12389

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Renal cell carcinoma (RCC) is one of the most aggressive malignancies of the genito-urinary tract, having a poor prognosis especially in patients with metastasis. Surgical resection remains the gold standard for localized renal cancer disease, with radiotherapy (RT) receiving much skepticism during the last decades. However, many studies have evaluated the role of RT, and although renal cancer is traditionally considered radio-resistant, technological advances in the RT field with regards to modern linear accelerators, as well as advanced RT techniques have resulted in breakthrough therapeutic outcomes. Additionally, the combination of RT with immune checkpoint inhibitors and targeted agents may maximize the clinical benefit. This review article focuses on the role of RT in the therapeutic management of renal cell carcinoma.

引用

页码：1365 / 1377

页数：13

共 89 条

[1] Immune biomarkers of treatment failure for a patient on a phase I clinical trial of pembrolizumab plus radiotherapy
Alexander, Gregory S.
Palmer, Joshua D.
Tuluc, Madalina
Lin, Jianqing
Dicker, Adam P.
Bar-Ad, Voichita
Harshyne, Larry A.
Louie, Jennifer
Shaw, Colette M.
Hooper, D. Craig
Lu, Bo
[J]. JOURNAL OF HEMATOLOGY & ONCOLOGY, 2016, 9
[2] Survival After Complete Surgical Resection of Multiple Metastases From Renal Cell Carcinoma
Alt, Angela L.
Boorjian, Stephen A.
Lohse, Christine M.
Costello, Brian A.
Leibovich, Bradley C.
Blute, Michael L.
[J]. CANCER, 2011, 117 (13) : 2873 - 2882
[3] Local control rates of metastatic renal cell carcinoma (RCC) to the bone using stereotactic body radiation therapy: Is RCC truly radioresistant?
Amini, Arya
Altoos, Basel
Bourlon, Maria T.
Bedrick, Edward
Bhatia, Shilpa
Kessler, Elizabeth R.
Flaig, Thomas W.
Fisher, Christine M.
Kavanagh, Brian D.
Lam, Elaine T.
Karam, Sana D.
[J]. PRACTICAL RADIATION ONCOLOGY, 2015, 5 (06) : E589 - E596
[4] Blanco Angel I, 2011, Cancers (Basel), V3, P4010, DOI 10.3390/cancers3044010
[5] Buti Sebastiano, 2020, Cancer Treat Res Commun, V22, P100161, DOI 10.1016/j.ctarc.2019.100161
[6] Role of radiotherapy in improving activity of immune-modulating drugs in advanced renal cancer: Biological rationale and clinical evidences
Buttigliero, Consuelo
Allis, Simona
Tucci, Marcello
Zichi, Clizia
Leone, Gianmarco
Di Stefano, Rosario Francesco
Redda, Maria Grazia Ruo
Ricardi, Umberto
Scagliotti, Giorgio Vittorio
Di Maio, Massimo
Filippi, Andrea Riccardo
[J]. CANCER TREATMENT REVIEWS, 2018, 69 : 215 - 223
[7] Calvo FA, 2013, STRAHLENTHER ONKOL, V189, P129, DOI 10.1007/s00066-012-0272-3
[8] Results of whole brain radiotherapy and recursive partitioning analysis in patients with brain metastases from renal cell carcinoma: A retrospective study
Cannady, SB
Cavanaugh, KA
Lee, SY
Bukowski, RM
Olencki, TE
Stevens, GHJ
Barnett, GH
Suh, JH
[J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 58 (01): : 253 - 258
[9] Evaluation and Management of the Renal Mass
Chen, David Y. T.
Uzzo, Robert G.
[J]. MEDICAL CLINICS OF NORTH AMERICA, 2011, 95 (01) : 179 - +
[10] Systemic Therapy for Metastatic Renal-Cell Carcinoma
Choueiri, Toni K.
Motzer, Robert J.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (04) : 354 - 366

← 1 2 3 4 5 6 7 8 9 →